Potential Treatments

Please see "Ongoing Research" for recent updates

December 15, 2020

• Most doses of a COVID-19 treatment are going unused

December 3, 2020

• Oral Drug Blocks SARS-CoV-2 Transmission: Georgia State Biomedical Sciences

November 14, 2020

• Antidepressant may prevent severe COVID-19, U.Va. research finds

November 5, 2020

• Flu shot could help boost ability to fight COVID-19, University of Florida researchers say

September 20, 2020

• Advances in ICU care are saving more patients
• Drug used to treat COVID in cats may be effective treatment

September 19, 2020

• This theory might explain "COVID toes" and other mysteries

September 16, 2020

• Eli Lilly reports a reduced rate of hospitalization using antibody treatment

September 14, 2020

• Can melatonin treat COVID? UB clinical trial to find out

September 10, 2020

• What we've learned about treating COVID

September 4, 2020

• Six potential treatments identified

August 25, 2020

• AstraZeneca starts trial of COVID antibody treatment

August 24, 2020

• U Minnesota research team studies neutralizing monoclonal antibodies as possible treatment
• Six of the most promising COVID treatments so far

August 23, 2020

• FDA issues emergency use authorization for convalescent plasma to treat COVID
• Antibody drugs advancing to fill treatment gap

August 22, 2020

• COVID treatments: what's taking clinical trials so long?

August 18, 2020

• Federal study of COVID treatments enters a new phase

August 17, 2020

• Researchers hope this old-fashioned treatment will work for COVID

August 13, 2020

• Could one of these drugs be the next emergency treatment for COVID?

August 12, 2020

• Could cat drugs treat humans with COVID?

August 5, 2020

• NIH harnesses AI for diagnosis, treatment, and monitoring

August 4, 2020

• Critically ill COVID patients make quick recovery with RLF-100

July 30, 2020

• J&J vaccine protects monkeys
• Drugmakers race to build vaccine supply chains
• How the world made so much progress on vaccine so fast
• Inhaled corticosteroids in virus pandemics: a treatment for COVID?
• Wake Forest researchers creating 3D organs to test treatment efficacy
• Eli Lilly starts midstage study of treatment

July 29, 2020

• FDA nears decision authorizing COVID treatment with convalescent plasma
• 'Potent' neutralizing antibody studies and what they could mean for treatment
• Harvested anitbodies now being tested as a prevention tool against COVID

July 28, 2020

• Kansas State professor working to quickly find safe, successful treatment
• Pfizer foresees lasting demand for vaccine
• COVID could dodge some treatments
• What it takes to develop a vaccine
• Which treatments work, and how close are we to getting more?

July 27, 2020

• A possible weapon against the pandemic: printing human tissue

July 26, 2020

• Madagascar opens new treatment center

July 25, 2020

• West Texas doctor sees COVID improvement using inhaled steroid treatment
• Docs: learned knowledge helping treat patients
• Seaweed to the rescue, including as COVID treatment
• A weekly digest of latest COVID research

July 24, 2020

• Nature study IDs 21 existing drugs that could treat COVID
• Researchers study cannabis as treatment
• Astra Zeneca, Lilly, GSK, more share antibody secrets to speed manufacturing scale-up
• CEL-SCI announces early results with LEAPS vaccine/treatment
• Scientists researching ways to transfuse antibodies in treatment
• Drugs show 'positive results' at Mobile hospitals, recovery time shortened
• Treatment with lopinavir/ritonavir may raise bradycardia risk

July 23, 2020

• NIH to start 'flurry' of large studies of potential treatments
• NEJM: Hydroxychloroquine with/without azithromycin in mild, moderate COVID
• GWU researchers examine nitric oxide as potential COVID treatment
• Multiple sclerosis drug may help treat COVID, lead to faster recovery

July 22, 2020

• New antibody mix could form 'very potent' treatment

July 20, 2020

• Protein treatment trial 'a breakthrough'
• Studies provide glimpse at efficacy of vaccines

July 13, 2020

• Pfizer CEO raises expectations they can deliver a vaccine by fall
• US invests in small, untested company to deliver vaccine
• Remdesivir may reduce deaths, hasten recovery for patients
• Six months into pandemic, how much closer to a vaccine?
• Is inhaled steroid budesonide 'silver bullet' for COVID?
• Llama-based antibody treatment 'neutralizes' virus
• Unprecedented race for vaccine, in 5 charts
• WHO officials say antibodies may wane after several months
• Drugmakers will start vaccine production by end of summer
• U Michigan: drug that calms 'cytokine storm' lowers risk of dying on ventilators
• K-State signs agreement to help develop vaccine candidate

July 9, 2020

• U Miami researchers gear up for preclinical testing of vaccine
• Building blocks for antiviral drugs identified in UCSF rapid study

July 8, 2020

• US to pay $1.6 billion to Novavax for vaccine
• Can boosting interferons, the body's frontline virus fighters, beat COVID?

July 6, 2020

• Months of trial and error in the ICU offer clues on how to save patients
• CSL Behring begins phase II study of COVID therapy
• Emergent, J&J ink 5-year vaccine manufacturing deal
• Plasma therapy only right for some patients
• Drugs & therapies proven to work, which ones don't
• New Hackensack U Medical Center care, research center to study COVID treatments
• WHO: vaccine highly likely by 2021

July 5, 2020

• FDA commissioner says he can't predict when vaccine will be ready
• MUSC Health physician: patient demographic changing as treatments evolve

July 3, 2020

• ICMR selects 12 institutes for clinical trial of vaccine
• Bay Area doctors explain treatments they're using now
• Sydney researchers test TB vaccine combo
• U Arizona startup to use lasers to detect COVID

July 2, 2020

• NIH 'optimistic' vaccine by end of 2020
• Second vaccine cleared for Phase 1, 2 human trials in India
• Trial of Moderna vaccine delayed, but July start still possible
• Early trial of vaccines by Pfizer, BioNtech promising: scientists
• Volunteers needed for new vaccine study at URMC
• One UK trial transforming treatments
• Tesla to make 'molecule printers' for vaccine developer CureVac
• Vaccine tracker: how close are we to a vaccine?
• Oxford U is leading the vaccine race
• China surprise frontrunner in vaccine race
• Pfizer's vaccine shows positive results
• COVID vaccines to enter late-stage trials by end of July

July 1, 2020

• Oxford offers best hope for vaccine this year, MPs told
• Virus shot from Pfizer, BioNtech Shows Promise in Early Test
• Inovio COVID vaccine shows promise in early-stage trial
• Synthetic antibody could prevent and treat COVID
• Japan's Kyushu Univ., startup create possible COVID-19 vaccine from silkworm protein
• Palm Beach couple gives $5M for vaccine quest
• $9.6B pledged for tests, vaccines at global event

June 30, 2020

• Why the race for a vaccine is complicated
• Explainer: How the race for COVID vaccine looks
• Updates on treatments being researched in Colorado

June 29, 2020

• Potential vaccine from China shows promise in human trials
• Oxford vaccine most advanced, says WHO
• MMR vaccine can help fight sepsis in COVID patients
• Effect on heart, AI use in treatment among Karnataka research proposals
• More than a dozen experimental vaccines being tested on humans. Here's what's next.
• Four lessons from past epidemic guide in search for treatments
• Hospitals experiment with treatments, balancing hope and evidence
• Gilead sets price for treatment as HHS buys doses
• COVID vaccine: will it be ready by fall?
• Study by U Toronto, National Jewish Hospital could lead to anti-inflammatory treatments
• Best ways to treat COVID? Remdesivir, plasma promising, but others needed

June 28, 2020

• Study reveals images of COVID's 'tentacles' in cells, helps ID new treatment
• How Moderna's Vaccine Timing Compares with JNJ and Pfizer
• Findings of professor reviewing every drug against COVID
• CBS: The race to find a vaccine
• New drug Fabiflu is here, but use with caution

June 27, 2020

• Made in Alberta vaccine prototypes to be tested on humans
• Vaxart says potential vaccine picked for 'Operation Warp Speed'
• COVID-19 doesn't change quickly, good news for vaccine makers

June 26, 2020

• Doctors see hope in new treatments
• Gout drug colchicine shows promise in treating COVID
• Could salt water fight COVID?
• U Ottawa scientist seeking edible vaccine for COVID
• Hope against COVID: Drug cuts death by a third and other findings
• MMR vaccine may be reason children are less affected by COVID
• Remdesivir set to become Europe's first COVID therapy
• How plasma therapy helped treat 170 COVID patients in Dubai
• Three promising treatments for COVID: No Cure Yet, But Progress
• Frontier Scientific on fast track for COVID-19 treatment
• Cow plasma used for potential antibody treatment
• Drug-hunter chases treatment as pandemic spreads
• Could a forgotten pneumonia treatment help COVID patients?
• Colorado State U moving forward with vaccine research
• U Chicago to assist with vaccine study
• Vaccine months away, but antibody treatment could be closer

June 25, 2020

• U KY: Artemisia Annua Could be Promising Treatment for COVID
• Alberta COVID vaccine advancing to human testing
• CSU receives more funding for its vaccine candidate
• Bay Area researchers race to find effective drug to treat COVID

June 24, 2020

• Breakthrough Drug for COVID May Be Risky for Mild Cases
• COVID vaccine may not work in older people, experts say

June 23, 2020

• Sanofi eyes approval of COVID vaccine by first half of 2021
• University of Minnesota's large study finds new drug targets
• Tulane U develops synthetic antibody against COVID
• Large NIH clinical trial for treatment

June 22, 2020

• Evaluating efficacy of adjunctive therapies: the role of vit. c and zinc
• How antibody therapies may help protect people from COVID before vaccine available
• Gilead targets remdesivir supply for 2M patients by year-end
• ClinicalTrials.gov: Effectiveness of Convalescent Immune Plasma Therapy

June 20, 2020

• Researchers ask if survivor plasma could prevent COVID
• Tocilizumab for treatment of patients with severe COVID: A retrospective cohort study

June 19, 2020

• MSU: Understanding protein interactions for COVID treatments
• Duo of antiviral drugs strongly inhibits COVID in lab

June 18, 2020

• Widely available drug cuts COVID deaths in study
• UV-C light can inactivate COVID, in Signify/Boston U study
• 'Nanosponges' soak up, neutralize COVID in lab study
• Avacta, U Glasgow discover potential COVID therapy

June 17, 2020

• Antibodies tested as possible treatment
• 2 clinical trials to use low-dose radiation to treat COVID
• WHO to update guidance for steroid treatment
• WHO urges caution on 'breakthrough' COVID drug
• Kamada produces plasma-based treatment
• World's first treatment drugs used in Leicester
• Aclaris Therapeutics Takes the Next Big Step Toward COVID

June 9, 2020

• The vaccines on trial - and when they may be ready
• Can a vaccine be developed in record time?

June 4, 2020

• Russian labs race to find a vaccine by fall, concerns raised about fast-tracking
• $2B global vaccine fund announced at Gavi summit
• Japanese researchers create tiny bronchi to develop COVID drug
• Why developing a successful vaccine is only half the battle

June 3, 2020

• Natural antibiotic 'outsmarts' superbugs
• Drug targets enzymes enabling virus to invade cells
• Why a vaccine may not be enough to end the pandemic

June 2, 2020

• Monkeys, ferrets offer needed clues in vaccine race
• COVID drug development could benefit from approach used against flu
• An important new tool for developing treatments, vaccines
• Researchers discuss vaccine development
• Convalescent plasma therapy is safe, with 76% of patients improving
• Sabin Vaccine Institute and the Aspen Institute Release Report on Vaccine Hesitancy
• Bharat Biotech CEO Expresses Satisfaction Over Vaccine Development Research
• Griffith U gene silencing technology to target COVID
• U MN researchers' graph could find COVID treatments

June 1, 2020

• Rare disease researcher offers unique pespective on search for treatment
• World's first human tests of COVID antibody treatment have Vancouver connection
• Russia approves 'game-changer' drug to treat COVID after promising study
• FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID with Heart Failure

May 29, 2020

• Ventilators may not be the best treatment for COVID
• Rye Brook doctor 'hopeful' clinical trial provides effective treatment
• Local hospitals participate in plasma study to find COVID treatment
• San Antonio's Southwest Research Institute screening possible COVID drugs - lots of them

May 28, 2020

• FDA welcomes variety of phase 2/3 trial designs for COVID therapies
• Big gene therapy names line up behind experimental vaccine
• Study shows more cancer patients die from COVID, but not necessarily for the reasons you'd suspect

May 27, 2020

• Bharat Biotech, Thomas Jefferson U sign deal to develop vaccine
• Research points to treatment for COVID cytokine storms
• Study finds first COVID treatment that significantly improves survival
• Use of survivor plasma is considered safe, but two new tests will see if it combats COVID

May 26, 2020

• The drug combination that may help us beat COVID
• First potential major COVID treatment, nitric oxide, may come from Shreveport
• Merck buys rights to develop promising antivral discovered at Emory U
• The search for COVID treatment expands

May 25, 2020

• Combination drug therapy for COVID treatment

May 24, 2020

• De Soto woman pioneers experimental plasma treatment
• Texas A&M scientist discovers first COVID treatment

May 23, 2020

• Mixed results for Gilead Sciences' COVID treatment
• Immune clue sparks treatment hope

May 22, 2020

• Oxford University submits research papers for second stage of COVID vaccine
• Blood from SARS survivor yields an antibody that neutralizes new COVID
• AstraZeneca receives $1 billion in US funding for Oxford U COVID vaccine
• Early study of COVID-19 vaccine developed in China sees mixed results
• New Zealanders hope to hook virus with decoy enzyme
• Prisma Health sees COVID-19 treatment trends evolve
• Treating mild COVID could help save everyone

May 21, 2020

• UT: How Supercomputers Are Getting Us Closer to a COVID-19 Vaccine
• University of Guelph researchers get $230K to develop potential COVID vaccine
• Utah researchers collect antibody-rich plasma for treatment
• How COVID hijacks cells
• Snapshots of potential treatments

May 20, 2020

• Llamas offer promise to prevent or treat COVID-19
• BIDMC-developed vaccines protect against COVID in non-human primates, study finds
• In race to find COVID treatment, CEO of tiny biotech is 'very optimistic'
• Preventing 'cytokine storm' may ease severe COVID symptoms
• Drug trial at Wash U shows early promise
• This biotech says its COVID drug topped Remdesivir
• Researchers: nitric oxide therapy safe, helps COVID patients breathe

May 18, 2020

• Biotech eyes treatment trial combining leronlimab, remdesivir
• Westport's BioSig gets FDA approval to move forward with potential treatment
• WUSTL global study to test malaria drug to protect health care workers
• Oak Ridge pharmaceutical company files patent for NELL1 signaling protein in COVID treatment
• UCLA tests hormone suppressant as COVID treatment for men

May 15, 2020

• New 'Warp-Speed' COVID Vaccine Efforts

May 14, 2020

• Development of PrEP for COVID-19 Could Allow Country to Open Safely Before a Vaccine Is Available

May 13, 2020

• Convalescent plasma therapy is treating patients in UAB research
• IU School of Medicine studying potential treatments

May 12, 2020

• FDA issues two guidances to accelerate treatments
• WHO sees "potentially positive data" on treatments

May 11, 2020

• Bharat Biotech says will do everything to make its program successful
• Companies Working to Accelerate the Development Process to Meet Urgent Demand
• Kinksa's mavrilimumab shows positive effect in severely ill patients

May 10, 2020

• Stanford's new COVID treatment approach: hit hard - and early
• With no vaccine in sight, locally made drug gets green light

May 9, 2020

• When will we have a COVID-19 vaccine?
• Drug a decade in the making could help reduce dangerous symptoms
• Could risky human challenge studies help find a vaccine sooner?

May 8, 2020

• NIH begins study of remedesivir with anti-inflammatory drug to treat COVID
• Study finds no hydroxychloroquine effect on death, severe COVID

May 6, 2020

• Valdosta State developing potential treatment for COVID

May 5, 2020

• Northeastern Professor Partners with Audax Medical Inc. to Combat COVID-19
• UVa Trial to Use Plasma in Exploring Potential COVID-19 Treatment
• Developing effective treatment could be key to fight, experts say
• Clinical trial underway in AZ to study potential treatment of more severe forms of COVID

May 4, 2020

• Llamas, Estrogen and Nicotine: The Unusual Treatments Researchers are Trying
• U Minnesota research finds four antiviral drugs effective in inhibiting COVID
• Scientists Discover Antibody that Blocks COVID from Infecting Cells
• Pharma giants granted COVID approvals but doubts remain on manufacturing global vaccine
• St. Louis University working on COVID-19 vaccine
• After 2 months of work, Alnylam has its top pick for COVID drug

May 3, 2020

• Researchers 'very confident' COVID vaccine will be developed

May 2, 2020

• Profits and pride at stake, the race for a vaccine intensifies

May 1, 2020

• Health officials eyeing at least one of 14 potential vaccines to fast-track 

April 30, 2020

• Hundreds of millions of COVID-19 vaccine doses could be ready in January

April 29, 2020

• Emory helps lead research on drug to help treat COVID-19 patients

April 28, 2020

• CSU researchers run COVID tests on those without symptoms

April 27, 2020

• The Race to Get Convalescent Plasma to COVID Patients
• Besides Remdesivir, These 2 Treatments Could Have Promise
• CEPI: Vaccine Could Potentially Be Available Later This Year

April 26, 2020

• Bill Gates' vaccine could be manufacturing at scale next year
• CSU researchers part of race to vaccine
• WVU Medicine doctor receives approval for COVID treatment
• How India will play a major role in a vaccine
• The little biotech company that could beat COVID
• Countries, companies risk billions in race for vaccine

April 25, 2020

• There's no treatment, but Virginia researchers are ramping up clinical trials to try to find one
• Vancouver biotech company tests Leronlimab drug
• Mount Sinai Stem Cell Therapy as Potential Treatment

April 24, 2020

• WHO, Partners Unveil Massive Vaccine, Treatment Effort
• Northwestern Medicine leads clinical trial to see if sarilumab could be effective treatment
• UT medical research points to antidepressant as possible treatment

April 23, 2020

• University of Montana researchers working toward vaccine
• Update on UChicago's research for a vaccine

April 22, 2020
Emory doctors tapped to shape federal guidelines on COVID treatment

April 21, 2020

• Belgian biotech firm claims antibody test 100% accurate, making thousands per week
• Could Columbia's new UV technology fight the spread of COVID?
• 'Arsenal' of treatments being studied in Tampa
• The need for antibody treatments amid COVID crisis
• Yale, hospitals update research in treating COVID
• Westerly Hospital patients get experimental plasma treatment
• URMC discussing methods of treatment for COVID patients
• HIV, Flu Drugs Prove Futile in Fight Against COVID
• NJ patients who got experimental plasma treatments making 'remarkable' recovery
• This game-changing COVID therapy already saving lives
• Rockefeller University using antibodies from survivors to develop potent therapies

April 20, 2020

• University of Idaho working on COVID cure
• San Diego scientists uncover 30 potential COVID drug therapies
• Did you survive COVID? Rutgers seeks blood donors for possible antibody treatments

April 14, 2020

• Vaccines, Antibodies and Drug Libraries. The Possible Treatments Researchers Are Excited About.
• Moderna's COVID-19 vaccine trial starts enrolling high-dose arm
• Potential new treatment for COVID by BenevolentAI startup enters trials
• UCinnci, UC Health to examine potential treatment
• Ohio State takes part in new research, treatment using plasma from recovered patients

April 13, 2020

• Could a 100-year-old vaccine protect against COVID?
• Global race to a COVID-19 vaccine
• U Tennessee Health Sciences making strides in treating COVID
• Experimental treatment leronlimab shows 'very promising' response in some patients
• The race for antibodies
• Racing to a cure: where we stand on treating coronavirus

April 12, 2020

• When will COVID-19 vaccine be ready?
• New Research Links TB's BCG Vaccine to Lower COVID-19 Infections
• Treatment: new findings may bring researchers a step closer
• Utah researchers examining mucus to pave way for treatment
• Researchers studying a variety of treatments in the pipeline
• US beginning trials of Japanese anti-viral drug as potential treatment

April 11, 2020

• Top UK scientist: '80 percent' confident a vaccine could be ready by September
• Houston Methodist doctor preps for new vaccine with VGXI
• Doctor treating COVID-19 patients gambles on clot-busting drug

April 10, 2020

• Could human challenge trials speed vaccine?
• Auburn Vet Medicine begins testing for vaccine candidates

April 9, 2020

• Pfizer says early studies of potential treatment shows promise
• Data for Regeneron arthritis drug could come in weeks
• Mercer pharmacy professor researching microparticle vaccine
• Nitric Oxide Investigated as Treatment

April 8, 2020

• The Best Hopes for a COVID Drug
• UTSA molecular compound research could lead to treatment
• With ventilators running out, doctors say the machines are overused for COVID-19

April 7, 2020

• Everything Must Go Right For Pharma's Bet on Fast COVID Vaccine
• MSU: National COVID-19 Convalescent Plasma website for providers, patients launched
• FDA: Human trials can begin for Emory antiviral

April 6, 2020

• A new antiviral pill heading into clinical trials offers hope for treatment

April 5, 2020

• U. Pittsburgh had head start on COVID vaccine
• GlaxoSmithKline Re-Teams With Chinese Biotech for COVID-19 Vaccine
• Scientists ID COVID-19 Drug That "Kills" Virus Within 48 Hours

April 3, 2020

• Bill Gates is funding new factories for 7 potential COVID vaccines

April 2, 2020

• Trial drug can significantly block early stages of COVID-19 in engineered human tissues

March 31, 2020

• New FDA program to accelerate coronavirus treatments
• COVID-19 vaccine candidates: 6 front-runners
• Altimmune teams with Alabama university on COVID-19 vaccine

March 30, 2020

• LSU DeepDrug Team Uses AI to Discover New Treatments for COVID

March 27, 2020

• Amid critical shortage, pandemic ventilator inventor makes design open source
• U Florida Open Source Ventilator Project
• Could vilified tobacco plant be lifesaver against COVID-19?
• Hopkins-led COVID-19 treatment research funded
• Gates, Zuckerburg together fund COVID-19 research
• MIT experimental peptide could block COVID-19
• Is COVID vaccine close? Prof. Martin Bachmann on stopping a pandemic

March 26, 2020

• A possible treatment for COVID-19 and an approach for developing others
• Scientists Use Stem Cells to Treat COVID-19 Patients in China

March 25, 2020

• Duke Joins First National Effort to Test a Potential COVID-19 Therapy

March 23, 2020

• Emory's DRIVE, Ridgeback partnering for drug vs. coronavirus
• UAH joins supercomputing effort to find drugs effective against COVID-19
• Scientists racing to find best drugs to treat COVID-19

March 22, 2020

• COVID-19: French researcher reports successful drug trial
• Coronavirus Research at URMC
• UW researchers respond to novel coronavirus
• Winnipeg biotech company says COVID-19 treatment nearing production

March 21, 2020

• Might the Experimental Drug Remdesivir Work Against COVID-19?
• Investigating the New Coronavirus with Karla Satchell, PhD, Northwestern Medicine

March 20, 2020

• HHS welcomes partners for COVID-19 diagnosis and treatment
• FDA opens up Bellerophon's gas therapy for COVID-19, stock rockets
• Is Hydroxycholorquine the answer to the COVID-19 pandemic? Inside the race to find a cure
• MILabs enhances preclinical diagnostic U-CT system for COVID-19 research
• McMaster researchers get $1.8 million to fight COVID-19
• UW treating COVID-19 patients with anti-malarial drug - researcher calls it 'very promising'
• Pitt Researchers Attach Coronavirus to Genetically Modified Measles Vaccine
• UTSW Studies Existing Drugs to fight COVID

March 19, 2020

• Blood from recovered COVID-19 patients is a key resource for scientists
• COVID-19's Stop-Gap Solution Until Vaccines and Antivirals Are Ready
• FDA testing coronavirus treatments, including chloroquine, plasma from recovered COVID-19 patients
• AbCellera, Eli Lilly to Develop Antibody Products for COVID Treatment, Prevention

March 17, 2020

• Coronavirus Australia: Queensland researchers find 'cure,' want drug trial
• The Latest on the Biopharmaceutical Industry's Efforts to Beat Coronavirus

March 16, 2020

• Coronavirus vaccine test opens with 1st doses

March 14, 2020

• Dutch researchers first to find COVID-19 anitbodies: report

March 12, 2020

•  How doctors can potentially significantly reduce the number of deaths from COVID-19

March 9, 2020

• AbbVie Partnering with Global Authorities to Determine Efficacy of HIV Drug in Treating COVID-19

March 6, 2020

• Stanford creates new coronavirus test that produces fast results

March 4, 2020

• Vir and Alynlam Expand Collaboration to Advance RNAi Therapeutics for Coronoavirus Treatment

March 3, 2020

• Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800

February 26, 2020

• Gilead Sciences Initiates Two Phase 3 Clinical Studies COVID-19 Treatment

February 25, 2020

• Aequor Supplying Advanced Surface Cleaners to China

February 11, 2020

• InveniAI has identified over 100 drug candidates that could be repurposed to treat COVID-19

January 28, 2020

• Johnson & Johnson is using Janssen's AdVac and PER.C6 technology to find a vaccine candidate